Nicola Fazio Selected Research

Nicola Fazio Research Topics

Disease

70	Neoplasms (Cancer) 02/2024 - 02/2004
46	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 04/2013
10	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2003
9	Adenocarcinoma 10/2023 - 04/2007
9	Neoplasm Metastasis (Metastasis) 08/2022 - 09/2002
8	Disease Progression 10/2023 - 03/2014
8	Neuroendocrine Carcinoma 10/2023 - 01/2006
6	Merkel Cell Carcinoma 12/2021 - 01/2020
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 04/2007
5	Fatigue 10/2021 - 03/2016
5	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2002
5	Primitive Neuroectodermal Tumors (PNET) 01/2018 - 09/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 01/2007
4	Carcinoid Tumor (Carcinoid) 01/2023 - 11/2010
4	Carcinoma (Carcinomatosis) 05/2013 - 05/2006
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2023 - 09/2007
3	COVID-19 01/2023 - 01/2021
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 05/2013
3	Hyperglycemia 01/2021 - 01/2018
3	Infections 01/2018 - 04/2007
3	Neutropenia 08/2007 - 01/2003
2	Microsatellite Instability 11/2023 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2016
2	Hypertension (High Blood Pressure) 10/2021 - 03/2014
2	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 11/2014
2	Stomatitis 01/2018 - 03/2016
2	Necrosis 03/2017 - 09/2008
1	Pheochromocytoma 02/2024
1	Paraganglioma (Paragangliomas) 02/2024
1	Leukemia 12/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Pneumonia (Pneumonitis) 01/2023

Drug/Important Bio-Agent (IBA)

20	Everolimus FDA Link 09/2022 - 04/2013
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2007
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2024 - 11/2010
7	Biomarkers (Surrogate Marker)IBA 09/2022 - 09/2016
6	Peptide Receptors (Peptide Receptor)IBA 02/2024 - 11/2016
6	Radioisotopes (Radionuclides)IBA 02/2024 - 11/2016
6	Sunitinib (Sutent)FDA Link 12/2023 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2014
6	Octreotide (Sandostatin)FDA LinkGeneric 12/2020 - 11/2010
5	avelumabIBA 12/2021 - 01/2020
5	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2007
4	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 05/2013
4	Capecitabine (Xeloda)FDA Link 01/2021 - 10/2009
3	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2017
3	Circulating Tumor DNAIBA 04/2024 - 04/2023
3	lanreotide (Somatuline)FDA Link 01/2023 - 02/2004
3	Chromogranin AIBA 03/2022 - 06/2017
3	TOR Serine-Threonine KinasesIBA 01/2021 - 12/2015
3	Gemcitabine FDA Link 01/2020 - 05/2013
3	PlatinumIBA 11/2019 - 03/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 05/2013
3	Docetaxel (Taxotere)FDA Link 02/2010 - 01/2003
2	cabozantinibIBA 12/2023 - 08/2023
2	Monoclonal AntibodiesIBA 10/2023 - 01/2021
2	DOTA-Tyr(3)- 90Y-octreotideIBA 06/2021 - 01/2006
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 12/2015
2	methylamphotericin B (AME)IBA 01/2018 - 09/2014
2	dactolisibIBA 02/2016 - 12/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2014
2	Epirubicin (Ellence)FDA LinkGeneric 09/2008 - 08/2007
2	Leucovorin (Folinic Acid)FDA Link 09/2007 - 09/2002
1	GalliumIBA 02/2024
1	Yttrium-90IBA 02/2024
1	Lutetium-177IBA 02/2024
1	Peptides (Polypeptides)IBA 02/2024
1	Panitumumab (Vectibix)FDA Link 10/2023
1	trifluridine tipiracil drug combinationIBA 10/2023
1	zolbetuximabIBA 10/2023
1	pembrolizumabIBA 10/2023
1	Immunoglobulin G (IgG)IBA 10/2023
1	ClaudinsIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	NivolumabIBA 08/2023
1	IpilimumabIBA 08/2023
1	COVID-19 VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Cadherins (E-Cadherin)IBA 11/2022
1	SynaptophysinIBA 03/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	ribociclibIBA 01/2022
1	palbociclibIBA 01/2022
1	trilaciclibIBA 01/2022
1	abemaciclibIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021

Therapy/Procedure

37	Therapeutics 02/2024 - 02/2004
28	Drug Therapy (Chemotherapy) 02/2024 - 09/2002
6	Radiotherapy 10/2023 - 10/2009
5	Neoadjuvant Therapy 11/2023 - 05/2009
4	Adjuvant Chemotherapy 10/2023 - 04/2007
3	Combined Modality Therapy 10/2023 - 11/2017
2	Immunotherapy 01/2022 - 01/2021
2	Chemoradiotherapy 01/2015 - 11/2014
2	FPEPIR regimen 09/2008 - 04/2007
1	Precision Medicine 01/2023
1	Orchiectomy (Orchidectomy) 08/2022